Leaders in Pharmaceutical Business Intelligence (LPBI) Group

PART 5: Publications on Cancer & Oncology by LPBI’s Cancer Research Team

Scenario C: Cancer Research Team @ Leaders in Pharmaceutical Business Intelligence (LPBI) –+10 MDs & PhDs, LPBI’s Expert, Authors, Writers

http://pharmaceuticalintelligence.com/contributors-biographies/

PART 6: Protected: Prospective Business Partners and Valuation of Scenarios A & B & C

PART 7: Cancer-related Pharma and Biotech Companies in Switzerland and in Germany

 

PART 2: Cancer Content Indexing Scenario A Articles on Cancer-Related Topic in http://pharmaceuticalintelligence.com Open Access Online Scientific Journal   Curator: Stephen J Williams, PhD    5/5/2014 – OUT OF 1892 articles to date 746 involve the keyword CANCER   Cancer biology & innovations in cancer therapy 367 Personalized medicine & genomic research 259 Genome biology 258 Cell biology, signaling cell circuits 237 Disease biology, small molecules in development of therapeutic drugs 228 Biomarkers & medical diagnostics 226 Biological networks, gene regulation & evolution 213 Population health management, genetics & pharmaceutical 195 Molecular gentics & pharmaceutical 175 Technology transfers biotech and pharmaceutical 162 Genomic testing: methodology for diagnosis 149 Frontiers in cardiology and cardiovascular diseases 145 Computational biology/systems and bioinformatics 144 Chemical biology and its relations to metabolic disease 138 Bioinstrumentation in experimental life sciences research 136 Health economics and outcomes research 135 Chemical genetics 130 Medical & population genetics 104 Pharmaceutical r&d investment 104 Regulated clinical trials; design, methods, components and irb related issues 99 Interviews with scientific leaders 88 FDA regulatory affairs 83 Metabolomics 79 International global work in pharmaceutical 75 Uncategorized 74 Imaging-based cancer patient management 72 Cardiovascular pharmacogenetics 69 Pharmacogenomics 63 Proteomics 63 Pharmaceutical industry compettive intelligence 62 Human immune system in health and in disease 60 Medical devices r&d investment 60 Scientist: career considerations 60 Biosimilars 59 Population health management, nutrition & phytochemistry 59 Pharmaceutical analytics 55 Stem cells for regeneration 51 Cancer prevention research & programs 50 Systemic inflammatory response related disorders 49 Medical imaging technology, image processing 47 Statistical methods for reseach evaluation 47 Nutrition 45 Ecosystems & industrial concentration in the medical device sector 41 Nitric oxide in health and disease 40 Health law and patient safety 39 Liver & digestive diseases research 36 Biomedical measurement science 35 Nanotechnology for drug delivery 35 Translational science 34 Drug delivery platform technology 33 Genomic endocrinology, preimplantation genetic diagnosis & reproductive genomics 29 Healthcare it 28 Alzheimer¹s disease 27 Nutrigenomics 27 Bone disease and musculoskeletal disease 25 Cardiac and cardiovascular surgical proceedures 25 Infectious disease & new antibiotic targets 22 Advanced drug manufacturing 21 Cerebrovascular and neuro&degenerative diseases 18 Curation 17 Cancer 15 Coagulation therapy and internal bleeding 15 Reproductive biology & bio instrumentation 14 Glycobiology; biopharmaceutical production, pharmacodynamics and pharmacokinetics 13 Cytoskeleton 12 Innovations in neurophysiology & neuropsychology 12 Calcium signaling 11 Healthcare reform 11 Immunodiagnostics 8 Innovation in immunology diagnostics 8 Regenerative biology and medicine 8 Signaling 8 Diabetes mellitus 7 Academic publishing 6 Conference coverage with social media 6 Drug toxicity 6 Human sensation and cellular transduction: physiology and therapeutics 6 Intellectual property, innovations, commercialization, investment in technological breakthrough 6 Ca++ triggered activation 5 Circulating progenitor cells 5 Diagnostic immunology 5 Calmodulin kinase & contraction 4 Patient experience: personal memories of invasive medical intervention 4 Hematology 3 Na-k transport 3 Open access journals 3 Pain, etiology, genetics & innovations in treatment 3 Cancer screening 2 Ionic transporters na 2 Scientific & biotech conferences: press coverage 2 Water transporters 2 Autologous cell therapy 1 Automated cell processing 1 Ca 1 Infectious disease immunodiagnostics 1 K 1 Na-k-atpase 1 Nephrology 1 Nephrology & regenerative medicine 1 Neurodegenerative diseases 1

PART 3: 

Internet EXPOSURE: Global VIEWS of Articles on

Cancer-Related Topic in

http://pharmaceuticalintelligence.com 

Articles viewed by e-Readers more than 500 times

in bold more than 1,000

Semantic Classification of Articles’ Title Content: Stephen, J Williams, PhD

 

Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?

5,408

Contributors’  Biographies

2,555

Mesothelin: An early detection biomarker for cancer (By Jack Andraka)

2,541

About

1,912

BioMed e-Series

1,903

Problems of vegetarianism

1,872

AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo

1,660

Paclitaxel vs Abraxane (albumin-bound paclitaxel)

1,321

“The Molecular pathology of Breast Cancer Progression”

1,286

Recent comprehensive review on the role of ultrasound in breast cancer management

1,144

Introduction to Transdermal Drug Delivery (TDD) system and nanotechnology

1,141

Mitochondria: Origin from oxygen free environment, role in aerobic glycolysis, metabolic adaptation

1,114

Biosimilars: Intellectual Property Creation and Protection by Pioneer and by Biosimilar Manufacturers

1,040

Future of Calcitonin…?

1,034

Issues in Personalized Medicine in Cancer: Intratumor Heterogeneity andBranched Evolution Revealed by Multiregion Sequencing

947

Non-small Cell Lung Cancer drugs – where does the Future lie?

908

CD47: Target Therapy for Cancer

907

Closing the Mammography gap

890

DNA Structure and Oligonucleotides

883

Open Access Scientific Journal

855

Nitric Oxide has a ubiquitous role in the regulation of glycolysis -with a concomitant influence on mitochondrial function

851

Mitochondrial fission and fusion: potential therapeutic targets?

833

Crucial role of Nitric Oxide in Cancer

787

Biosimilars: CMC Issues and Regulatory Requirements

783

Nanotechnology: Detecting and Treating metastatic cancer in the lymph node

759

Akt inhibition for cancer treatment, where do we stand today?

749

Paradigm Shift in Human Genomics – Predictive Biomarkers and Personalized

Medicine – Part 1

747

Partnerships & Funding

739

Mitochondrial Damage and Repair under Oxidative Stress

706

Sunitinib brings Adult Acute Lymphoblastic Leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade

695

Novel Cancer Hypothesis Suggests Antioxidants Are Harmful

689

Differentiation Therapy – Epigenetics Tackles Solid Tumors

633

Interview with the co-discoverer of the structure of DNA: Watson on The Double Helix and his changing view of Rosalind Franklin

628

Relation of Diet and Cancer

622

Big Data in Genomic Medicine

620

Immunoreactivity of Nanoparticles

609

Directions for Genomics in Personalized Medicine

587

Confined Indolamine 2, 3 dioxygenase (IDO) Controls the Hemeostasis of Immune Responses for Good and Bad

579

International Scientific Delegations

570

2013 Genomics: The Era Beyond the Sequencing of the Human Genome: Francis Collins, Craig Venter, Eric Lander, et al

536

Gamification of Genomics and Proteomics Research

531

The Development of siRNA-Based Therapies for Cancer

527

Nanotechnology Tackles Brain Cancer

524

Heroes in Medical Research: Barnett Rosenberg and the Discovery of Cisplatin

517

Ubiquitin-Proteosome pathway, Autophagy, the Mitochondrion, Proteolysis and Cell Apoptosis: Part III

517

Expanding the Genetic Alphabet and Linking the Genome to the Metabolome

516

In focus: Melanoma Genetics

510

Nanotech Therapy for Breast Cancer

509

How mobile elements in “Junk” DNA promote cancer. Part 1: Transposon-mediated tumorigenesis

500

PART 4:

Content Curations in e-Publishing

Scenario B

BioMed e-Series C: Cancer and Oncology

http://pharmaceuticalintelligence.com/biomed-e-books/series-c-e-books-on-cancer-oncology/

THREE e-Books on Cancer, Volume One, Volume Two, Volume Three

• Volume One: Cancer Biology and Genomics for Disease Diagnosis
• Volume Two: Radiation Therapy and Immunotherapy in Oncology
• Volume Three: Nanotechnology in Drug Discovery and Drug Delivery
• Volume Four: Cancer Patients’ Resources on Therapies

 

PART 5:

Publications on Cancer & Oncology by

LPBI’s Cancer Research Team

Scenario C

Cancer Research Team @ Leaders in Pharmaceutical Business Intelligence (LPBI) –

+10 MDs & PhDs, LPBI’s Expert, Authors, Writers

http://pharmaceuticalintelligence.com/contributors-biographies/

• Stephen J. Williams, PhD, Senior Editor

sjwilliamspa@comcast.net

Cancer Research: Curations and Reporting: Stephen J. Williams, PhD [PENDING]

• Larry H Bernstein, MD, FCAP, Chief Scientific Officer, Member of the Board, COntent COnsultant for e-Series C: Cancer & Oncology and Expert, Author, Writer on Cancer, Cell biology, Signal transduction, Biochemistry

larry.bernstein@gmail.com

Cancer Research: Curations and Reporting: Larry [PENDING]

• Tilda Barliya, PhD, Editor

tildabarliya@gmail.com

Cancer Research: Curations and Reporting: Tilda [PENDING]

• Ritu Saxena, PhD, Editor

ritu.uab@gmail.com

Cancer Research: Curations and Reporting: Ritu [PENDING]

• Dror Nir, PhD, Editor

dror.nir@radbee.com

Cancer Research: Curations and Reporting: Dror [PENDING]

• Itzhak Golan, PhD, Senior Editor Immunotherapy in Cancer

I.Golan@swansea.ac.uk

• Raphael Nir, PhD, Expert, Author, Writer on Brain Cancer

rnir@sbhsciences.com

Cancer Research: Curations and Reporting: Raphael [PENDING]

• Demet Sag, PhD, Expert, Author, Writer on  Cancer Gemonics and Pharmacology

demet.sag@gmail.com

Cancer Research: Curations and Reporting: Raphael [PENDING]

• Ziv Raviv, PhD, Expert, Author, Writer on Cancer, Cell biology, Signal transduction, Biochemistry

zraviv06@gmail.com

Cancer Research: Curations and Reporting: Ziv [PENDING]

• Aviva Lev-Ari, PhD, RN, Editor-in-Chief – BioMed e-Series of e-Books

avivalev-ari@alum.berkeley.edu

Cancer Research: Curations and Reporting: Aviva Lev-Ari, PhD, RN

PART 6:

Protected: Prospective Business Partners and Valuation of Scenarios A & B & C

PART 7:

Cancer-related Pharma and Biotech Companies in Switzerland and in Germany

GERMANY

 

Ibt Bebig

Berlin, Germany

Cancer Treatments

 

Sirtex Medical

Bonn, Germany

Cancer Treatments

 

Cato Research

Cologne, Germany

Full Service Contract Research

 

United Biosource (Express Scripts)

Cologne, Germany

Biopharmaceutical Consulting & Services

 

IDT Biologika

Dessau-Rosslaud, Germany

Contract Research, Development & Manufacturing (Biologics, Liquid Small Molecules)

 

Bayer

Leverkusen, Germany

Biotech/Pharma/Chemical Giant

 

4SC	Planegg, Germany	Autoimmune & Cancer Small Molecules
Allergopharma (Merck KgaA)	Reinbek, Germany	Specific Immunotherapy Allergy Treatment
Biobase	Wolfenbüttel, Germany	Biological Databases

 

SWITZERLAND

 

Genedata

Basel, Switzerland

Bioinformatics

 

 

Carbogen Amcis	Bubendorf, Switzerland	Drug Development & Commercialization
NovImmune	Geneva, Switzerland	Monoclonal Antibodies
United Biosource (Express Scripts)	Geneva, Switzerland	Biopharmaceutical Consulting & Services

 

Carbogen Amcis

Hunzenschwil, Switzerland

Drug Development & Commercialization

 

Enzo Life Sciences

Lausen, Switzerland

Life Sciences R&D Products

 

Bio-Xtal

Lutry, Switzerland

Protein Expression & Structural Biology

 

Accuray

Morges, Switzerland

Directed Radiation Therapy

 

Lonza

Visp, Switzerland

Small Molecules, Biologics

 

PSI

Zug, Switzerland

Clinical Research Organization

 

Celerion

Zurich, Switzerland

Clinical Research